Peptide Initiative

Peptides · Peptide comparison

Acetyl Hexapeptide-3 (Argireline) vs Leuphasyl

SNARE complex inhibitor that reduces expression wrinkles through topical neuromuscular modulation — the 'Botox in a bottle' peptide.

Enkephalin-mimetic cosmetic peptide that reduces expression wrinkles by modulating acetylcholine release at the neuromuscular junction, offering a Botox-like topical alternative.

  • Cosmetic
  • Cosmetic

At a glance

Quick comparison

Dose rangeAcetyl Hexapeptide-3 (Argireline)5–10 %Leuphasyl5–5 %
FrequencyAcetyl Hexapeptide-3 (Argireline)Once dailyLeuphasylOnce daily
AdministrationAcetyl Hexapeptide-3 (Argireline)TopicalLeuphasylTopical application (serums, creams, ampoules)
Cycle lengthAcetyl Hexapeptide-3 (Argireline)Ongoing/indefiniteLeuphasylOngoing/indefinite
Onset speedAcetyl Hexapeptide-3 (Argireline)Moderate (1-2 weeks)LeuphasylSlow (5+ weeks)
Evidence levelAcetyl Hexapeptide-3 (Argireline)Limited human trialsLeuphasylModerate human trials (Phase 1-2)

Efficacy

Benefit ratings

Expression Wrinkle Reduction

Acetyl Hexapeptide-3 (Argireline)85%
LeuphasylNo recorded rating

Non-Invasive Treatment

Acetyl Hexapeptide-3 (Argireline)92%
LeuphasylNo recorded rating

Safety Profile

Acetyl Hexapeptide-3 (Argireline)95%
LeuphasylNo recorded rating

Wrinkle Reduction

Acetyl Hexapeptide-3 (Argireline)No recorded rating
Leuphasyl82%

Skin Smoothing

Acetyl Hexapeptide-3 (Argireline)No recorded rating
Leuphasyl78%

Anti-Aging Prevention

Acetyl Hexapeptide-3 (Argireline)No recorded rating
Leuphasyl75%

Technical data

Compound specifications

Acetyl Hexapeptide-3 (Argireline)

Molecular formula
C35H62N14O11S
Molecular weight
887.0 Da
Half-life
Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7
Bioavailability
Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery
CAS number
616204-22-9

Leuphasyl

Molecular formula
C29H39N5O7
Molecular weight
569.65 g/mol
Half-life
Topical application (local activity, systemic half-life not applicable)
Bioavailability
Limited (topical peptide; skin penetration challenged by hydrophilic nature and molecular size)
CAS number
64963-01-5

Protocols

Dosing compared

Acetyl Hexapeptide-3 (Argireline)

Topical

  • 5-10% concentration (cream or serum)Twice daily (morning and evening) · Minimum 28-30 days; ongoing use to maintain effectUsed as a leave-on skin cream or serum. In studies, a 10% formula applied twice a day around the eyes reduced wrinkle depth by about 17% after 15 days and up to 27-30% after 30 days. It works on the skin surface only and is not injected. [1][2]

Leuphasyl

Topical

  • 2% Leuphasyl in formulationOnce or twice daily · 4-8 weeksLowest concentration shown to give significant wrinkle reduction in cosmetic testing; 2% was the threshold at which measurable improvement appeared over ~2 months of daily use [6].
  • 5% Leuphasyl in formulationOnce or twice daily · At least 4 weeksManufacturer in-vivo concentration; 5% Leuphasyl reduced wrinkles ~11% after 28 days, and ~25% (up to 47%) when paired with 5% Argireline [6].

Applications

Best suited for

Acetyl Hexapeptide-3 (Argireline)

Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1][4].
Those with needle phobia who want botulinum toxin-like effects without injections
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [4].
People targeting crow's feet, forehead lines, and glabellar creases
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Leuphasyl

Expression line reduction
Leuphasyl is particularly well-suited for individuals focused on expression line reduction. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Fine line prevention
Leuphasyl is particularly well-suited for individuals focused on fine line prevention. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Age management
Leuphasyl is particularly well-suited for individuals focused on age management. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Non-invasive wrinkle reduction
Leuphasyl is particularly well-suited for individuals focused on non-invasive wrinkle reduction. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Safety profile

Side effects

Acetyl Hexapeptide-3 (Argireline)

Common

  • Mild Skin Irritation
  • Transient Redness
  • Slight Dryness
  • Stinging on Compromised Skin

Uncommon

  • Contact Dermatitis

Serious

  • Allergic Contact Dermatitis

Leuphasyl

Common

  • Mild discomfort at treatment site
  • Mild skin tingling
  • Mild redness at application site

Uncommon

  • Temporary skin dryness

Serious

  • Severe allergic reaction

Research status

Safety & evidence

Acetyl Hexapeptide-3 (Argireline)

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. In cell-culture testing, significant cytotoxicity appeared only at concentrations 18 to 10,000 times higher than the reference drug doxorubicin [5]. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.

Contraindications

  • Known hypersensitivity to acetyl hexapeptide-3 or formulation components
  • Active skin infections or open wounds at the application site
  • No known systemic contraindications at cosmetic concentrations
  • Use with caution in individuals with neuromuscular disorders (theoretical concern)

Leuphasyl

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
Leuphasyl (Pentapeptide-18) has been studied in cosmetic research for over 15 years. This topical enkephalin-mimetic peptide demonstrates an excellent safety profile in cosmetic formulations, with no reported serious adverse effects in clinical applications. As a topical cosmetic ingredient, it avoids systemic absorption concerns associated with injectable treatments. The peptide is well-tolerated across all skin types including sensitive skin. Individual responses can vary with formulation and concentration, but most effects are manageable with standard cosmetic application protocols.

Contraindications

  • Known hypersensitivity to peptides
  • Open wounds or broken skin at application site
  • Active dermatological infections at application site

Decision guide

Which is right for you?

Acetyl Hexapeptide-3 (Argireline)

Choose Acetyl Hexapeptide-3 (Argireline) if…

  • Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
  • Those with needle phobia who want botulinum toxin-like effects without injections
  • People targeting crow's feet, forehead lines, and glabellar creases
  • Individuals looking for preventive anti-wrinkle treatment to slow expression line formation

Leuphasyl

Choose Leuphasyl if…

  • Expression line reduction
  • Fine line prevention
  • Age management
  • Non-invasive wrinkle reduction